News Detail
London, United Kingdom and Geneva Switzerland, 4 Dec 2024: GSK plc and Medicines for Malaria Venture (MMV) announced today that the World Health Organization (WHO) has awarded prequalification to tafenoquine, the first single-dose medicine for the prevention of rel......
View Details
Source : Medicines for Malaria Venture
GSK plc
Medicines for Malaria Venture (MMV)
World Health Organization (WHO)
tafenoquine
single-dose medicine
Plasmodium vivax (P. vivax) malaria
Related News
- UT man duped of Rs 1.4 lakh in fake Patanjali treatment scam (13-01-2025)
- Kidney, liver damage in 3 new moms given faulty drip (13-01-2025)
- WB govt bans 10 intravenous fluids in hospitals for patient safety (13-01-2025)
- 15 lakh annual surgical site infections in India:ICMR study (13-01-2025)
- NCB and police seized Narcotic capsules in Hindaun City, one arrested (12-01-2025)
- Assam: Massive consignment of illicit cough syrup seized in Guwahati (12-01-2025)
- Police probe company behind tramadol diversion in Punjab (12-01-2025)
- ACB caught UP Pharmacy Council contract worker red-handed accepting bribe of Rs 5,000 (12-01-2025)
- Medical shop running without license, medicines worth 50 thousand seized (12-01-2025)
- Drug business under the guise of medicine shop: 600 injections seized (12-01-2025)